Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Price : 4.125 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 4.22 | 4.30 | 4.185 | 4.29 | 2.273M |
| Aug 20, 2026 | 4.255 | 4.29 | 4.045 | 4.14 | 1.471M |
| Aug 19, 2026 | 4.48 | 4.49 | 4.305 | 4.36 | 1.478M |
| Aug 18, 2026 | 4.345 | 4.40 | 4.26 | 4.31 | 1.411M |
| Aug 17, 2026 | 4.31 | 4.410 | 4.23 | 4.36 | 1.377M |
| Aug 14, 2026 | 4.03 | 4.35 | 3.96 | 4.31 | 2.334M |
| Aug 13, 2026 | 4.41 | 4.41 | 4.05 | 4.08 | 2.084M |
| Aug 12, 2026 | 4.32 | 4.505 | 4.255 | 4.32 | 2.721M |
| Aug 11, 2026 | 4.08 | 4.315 | 4.06 | 4.30 | 1.930M |
| Aug 10, 2026 | 4.17 | 4.275 | 4.04 | 4.05 | 2.184M |
| Aug 07, 2026 | 4.30 | 4.40 | 4.21 | 4.32 | 1.843M |
| Aug 06, 2026 | 4.16 | 4.375 | 3.92 | 4.26 | 3.362M |
| Aug 05, 2026 | 4.34 | 4.425 | 4.13 | 4.15 | 2.210M |
| Aug 04, 2026 | 4.53 | 4.57 | 4.275 | 4.31 | 5.768M |
| Aug 03, 2026 | 4.325 | 4.59 | 4.28 | 4.42 | 3.818M |
| Jul 31, 2026 | 3.93 | 4.275 | 3.87 | 4.23 | 3.583M |
| Jul 30, 2026 | 3.60 | 3.76 | 3.55 | 3.73 | 1.299M |
| Jul 29, 2026 | 3.80 | 3.956 | 3.55 | 3.56 | 1.253M |
| Jul 28, 2026 | 3.90 | 3.97 | 3.76 | 3.80 | 1.821M |
| Jul 27, 2026 | 3.71 | 3.99 | 3.687 | 3.91 | 1.931M |
| Jul 24, 2026 | 3.79 | 3.84 | 3.70 | 3.71 | 1.109M |
| Jul 23, 2026 | 3.77 | 3.84 | 3.76 | 3.79 | 1.075M |
| Jul 22, 2026 | 3.89 | 3.925 | 3.845 | 3.88 | 1.053M |
| Jul 21, 2026 | 3.87 | 3.92 | 3.81 | 3.91 | 1.164M |
| Jul 20, 2026 | 3.92 | 4.02 | 3.84 | 3.85 | 1.801M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 264.49 |
| Rigel Pharmaceuticals, Inc. | 45.16 |
| Marker Therapeutics, Inc. | 1.50 |
| Verastem, Inc. | 6.85 |
| Theriva Biologics, Inc. | 0.24 |
Price Related Metrics
| PE Ratio | 5.380 |
| PS Ratio | 1.785 |
| Price to Free Cash Flow | 3.746 |
| Earnings Yield | 18.59% |
| Market Cap | 681.61M |
| Operating PE Ratio | 2.945 |
| Normalized PE Ratio | 5.328 |